GlassScriptPhysician profile
Zachary Posey
NPI 1992901524
$2,490.69
in general payments reported to CMS, 2019-2025
20 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.64 · 2020: $113 · 2021: $334 · 2022: $350 · 2023: $681 · 2024: $408 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.09 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $688.86 | 2019-2025 | Lithovue, Accutrac, Tria Firm |
| C. R. Bard, INC. & Subsidiaries | $405.53 | 2023-2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $199.08 | 2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $193.23 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Astellas Pharma US INC | $183.22 | 2023-2024 | Xtandi, Myrbetriq |
| Rochester Medical Corporation | $163.38 | 2021-2022 | |
| Pfizer INC. | $127.55 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $120.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.40 | 2021-2022 | |
| Abbvie INC. | $67.36 | 2024 | |
| Urogen Pharma, INC. | $42.75 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $38.75 | 2025 | |
| Janssen Biotech, INC. | $34.71 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.67 | 2022 | |
| 180 Medical, INC. | $22.67 | 2024 | Gentlecath |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $21.79 | 2025 | Itind System |
| Angiodynamics, INC. | $19.15 | 2024 | Nanoknife |
| Amgen INC. | $18.34 | 2019 | |
| Becton, Dickinson and Company | $13.19 | 2019 | |
| Travere Therapeutics, INC. | $7.64 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Posey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.